Observations that chemical pan-HSPA inhibitors effectively blocked the proliferation of NSCLC and breast cancer cells [18,39] further confirm that HSPA2 and other HSPAs are redundant in their functions. This evidence concerns the gene HSPA2 and breast carcinoma.